Laryngeal neoplasm
MONDO:0021071A benign or malignant neoplasm involving the larynx.
Also known as: laryngeal neoplasm, laryngeal tumor, laryngeal tumour, larynx neoplasm, larynx neoplasm (disease), larynx tumor, larynx tumour, neoplasm of larynx
1566 clinical trials for this condition and its sub-types, 72 tagged with Laryngeal neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Laryngeal neoplasm
-
Larynx cancer 41 trials · 125 incl. sub-types
7 sub-types
- Laryngeal carcinoma 56 trials · 114 incl. sub-types Sub-types →
- Glottis cancer 0 trials · 10 incl. sub-types Sub-types →
- Supraglottis cancer 1 trial · 3 incl. sub-types Sub-types →
- Subglottis cancer 0 trials · 1 incl. sub-types Sub-types →
- Aryepiglottic fold cancer 0 trials
- Laryngeal cartilage cancer 0 trials
- Laryngeal sarcoma 0 trials Sub-types →
-
Glottis neoplasm 3 trials · 12 incl. sub-types
2 sub-types
- Glottis cancer 0 trials · 10 incl. sub-types Sub-types →
- Benign neoplasm of glottis 0 trials
-
Supraglottis neoplasm 0 trials · 3 incl. sub-types
2 sub-types
- Supraglottis cancer 1 trial · 3 incl. sub-types Sub-types →
- Epiglottis neoplasm 0 trials Sub-types →
-
Benign laryngeal neoplasm 1 trial · 2 incl. sub-types
6 sub-types
- Laryngeal papillomatosis 1 trial
- Benign neoplasm of epiglottis 0 trials
- Benign neoplasm of glottis 0 trials
- Benign neoplasm of subglottis 0 trials Sub-types →
- Laryngeal leiomyoma 0 trials
- Larynx squamous papilloma 0 trials
-
Subglottis neoplasm 0 trials · 1 incl. sub-types
2 sub-types
- Subglottis cancer 0 trials · 1 incl. sub-types Sub-types →
- Benign neoplasm of subglottis 0 trials Sub-types →
-
Laryngeal neuroendocrine neoplasm 0 trials
1 sub-type
- Laryngeal small cell carcinoma 0 trials
Most studied deeper sub-types
-
New pill-chemo combo takes on hard-to-treat cancers
Disease control Not yet recruitingThis study tests a new drug called SX-682 (a tablet) combined with the chemotherapy docetaxel in people whose head/neck, salivary gland, or prostate cancer has spread or returned after treatment. The goal is to find the right dose and see if the combination shrinks tumors. About …
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Triple therapy aims to shrink head and neck tumors before surgery
Disease control Not yet recruitingThis study tests a combination of an experimental drug (ficerafusp alfa), an immunotherapy (pembrolizumab), and targeted radiation before surgery for people with advanced head and neck cancer that is HPV-negative. About 45 participants will receive these treatments over several w…
Phase 1/2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New combo aims to shrink head and neck tumors before surgery
Disease control Not yet recruitingThis phase 2 trial tests whether giving a combination of the immunotherapy drug camrelizumab and two chemotherapy drugs (paclitaxel and carboplatin) before surgery can improve outcomes for people with advanced oral cavity or larynx cancer. Fifty participants will receive three cy…
Phase 2 • Sponsor: National Medical Research Radiological Centre of the Ministry of Health of Russia • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could a simple pill before surgery beat back head and neck cancer?
Disease control Not yet recruitingThis study tests whether taking a short course of capecitabine pills before surgery can shrink tumors and improve outcomes for people with HPV-negative head and neck cancer. About 75 adults with stage III or IVa cancer will be randomly assigned to either standard care or capecita…
Phase 2 • Sponsor: Sir Mortimer B. Davis - Jewish General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New study aims to understand laryngeal cancer Patients' recovery journey
Knowledge-focused Not yet recruitingThis study follows 120 people with laryngeal cancer to see how their quality of life, voice, swallowing, pain, and mood change before treatment and at 3, 6, and 12 months after. Researchers will use questionnaires to track these changes. The goal is to better understand recovery …
Sponsor: Saglik Bilimleri Universitesi • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New AI tool aims to make airway management safer for laryngeal cancer patients
Knowledge-focused Not yet recruitingThis study tests a computer algorithm (EAP-LC) that uses CT scans to predict the best path for placing a breathing tube in laryngeal cancer patients. Researchers will compare the algorithm's predictions to actual tube placement videos from 70 patients. The goal is to see if the a…
Sponsor: Eye & ENT Hospital of Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC